ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
항알레르기약 시장 규모는 향후 몇 년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 8.5%로 성장할 전망이며, 584억 7,000만 달러로 성장이 예측됩니다. 향후 성장을 촉진하는 요인으로는 세계의 알레르기 부담 증가, 급속 완화약에 대한 기호 고조, 알레르기를 일으키기 쉬운 인구 고령화, e파머시 플랫폼 보급, 알레르기 교육에 대한 정부의 지원 강화 등을 들 수 있습니다. 이 시장에 기대되는 주요 동향으로는 약물 전달 기술의 혁신, 졸리지 않는 항히스타민제의 출현, 맞춤형 알레르기 치료의 진보, 생물학적 요법의 연구 개발 확대, 알레르기 증상 관리를 위한 디지털 도구의 이용 등을 들 수 있습니다.
알레르기의 유병률 증가는 항알레르기약물 시장의 성장을 가속할 것으로 예측됩니다. 알레르기는 꽃가루, 진드기, 특정 음식물, 애완동물의 비듬 등 알레르겐에 대한 과민한 면역반응으로 가벼운 자극부터 생명을 위협할 수 있는 위중한 반응까지 다양한 증상을 일으킵니다. 꽃가루 알레르기, 천식, 습진, 식품 알레르기, 알레르기성 비염 등입니다. 알레르기 환자 수의 증가는 면역계를 약화시키고 일반적인 알레르겐에 대한 감수성을 높이는 환경오염 증가가 주요 원인이 되고 있습니다. 항알레르기제는 이러한 알레르겐으로부터 과녁을 좁힌 완화를 가져와 꽃가루 알레르기, 천식, 습진 등의 증상을 관리하는 데 필수적인 것이 되고 있습니다. 이러한 의약품은 히스타민이나 기타 유인을 차단함으로써 면역의 과잉 반응을 억제하고 일상의 쾌적함과 삶의 질을 향상시키고 있습니다. 예를 들어 2024년 11월 미국 질병예방통제센터는 미국 천식 환자 수가 2021년 2,496만 3,874명에서 2022년 2,679만 9,588명으로 증가했다고 보고했습니다. 이 천식 환자의 증가는 효과적인 알레르기 치료에 대한 요구의 확대를 강조하여 항알레르기약 시장의 성장을 뒷받침하고 있습니다.
항알레르기약 시장의 주요 진출기업은 보다 과녁을 좁힌 치료를 제공하고, 치료 성과를 높이며, 부작용을 경감하고, 심각한 알레르기 증상에 대처하기 위해, 단일클론항체 치료 등의 혁신적인 치료법 개발과 규제 당국의 승인 취득에 주력하고 있습니다. 단일클론항체 치료는 알레르기 반응에 관여하는 특정 면역 경로를 표적으로 차단함으로써 면역계의 기능을 모방하도록 설계된 실험실 내에서 설계된 단백질입니다. 이를 통해 보다 정확하고 지속적인 증상 완화가 가능해집니다. 예를 들면, 2024년 12월, 스위스에 본사를 둔 제약회사 가르데르마 SA는, 중등도로부터 심한 아토피성 피부염을 가지는 12세 이상의 성인과 소아의 치료로서, 네무루비오(네모리즈맙·일토)의 FDA 승인을 취득했습니다. 이 단클론항체는 외용 코르티코스테로이드 또는 칼시뉴린 저해제와 병용함으로써 인터루킨-31 수용체 안타고니스트로 작용하며 아토피 피부염에 동반되는 염증과 가려움증의 중요한 인자인 IL-31 신호를 차단함으로써 피부 상태를 개선하고 증상을 줄여줍니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 항알레르기약 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 항알레르기약 시장 : 성장률 분석
세계의 항알레르기약 시장 실적 : 규모 및 성장(2019-2024년)
세계의 항알레르기약 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 항알레르기약 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 항알레르기약 시장 : 약제 클래스별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
항히스타민제
코르티코스테로이드
충혈 제거 약
류코트리엔 억제제
비만 세포 안정제
기타 약품 클래스
세계의 항알레르기약 시장 : 알레르기 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
계절성 알레르기
통년성 알레르기
음식 알레르기
피부 알레르기
벌레 물린 알레르기
세계의 항알레르기약 시장 : 배합별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
정제
캡슐
시럽
코 스프레이
안약
주사제
세계의 항알레르기약 시장 : 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
온라인 약국
병원
오프라인 약국
클리닉
기타
세계의 항알레르기약 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
유아
성인
고령자
임산부
세계의 항알레르기약 시장 : 항히스타민 약제별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제1세대 항히스타민제
제2세대 항히스타민제
제3세대 항히스타민제
세계의 항알레르기약 시장 : 코르티코스테로이드별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
경구 코르티코스테로이드
비강 코르티코스테로이드
흡입 코르티코스테로이드
국소 코르티코스테로이드
세계의 항알레르기약 시장 : 충혈 제거 약제별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
경구 충혈 제거제
코 막힘 해소 스프레이
국소 충혈 제거제
세계의 항알레르기약 시장 : 류코트리엔 억제제별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
류코트리엔 수용체 길항제
류코트리엔 합성 억제제
세계의 항알레르기약 시장 : 비만 세포 안정제별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
크로모글리크산나트륨
네드크로밀 나트륨
세계의 항알레르기약 시장 : 기타 약제 클래스별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
면역요법제
생물제제
단일클론항체
제7장 지역별 및 국가별 분석
세계의 항알레르기약 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 항알레르기약 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
항알레르기약 시장 : 경쟁 구도
항알레르기약 시장 : 기업 프로파일
Pfizer Inc.
Johnson & Johnson
F. Hoffmann-La Roche AG
Merck & Co. Inc.
Bayer AG
제31장 기타 주요 기업 및 혁신 기업
Sanofi SA
AstraZeneca plc
Novartis AG
GSK plc
Amgen Inc.
Teva Pharmaceutical Industries Ltd.
Regeneron Pharmaceuticals Inc.
Perrigo Company plc
Cipla Limited
Dr. Reddy's Laboratories
Lupin Limited
Zydus Lifesciences Limited
Takeda Pharmaceutical Company Limited
Torrent Pharmaceuticals Ltd.
ALK-Abello A/S
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
항알레르기약 시장(2029년) : 새로운 기회를 제공하는 국가
항알레르기약 시장(2029년) : 새로운 기회를 제공하는 부문
항알레르기약 시장(2029년) : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
Anti-allergy medicine encompasses a wide range of pharmaceutical products formulated to prevent or ease symptoms triggered by allergic reactions. These medications work by targeting the immune system's response to allergens such as pollen, dust mites, pet dander, insect bites, specific foods, and drugs. They help alleviate discomfort by addressing symptoms like sneezing, itching, nasal congestion, hives, and watery eyes.
The primary categories of anti-allergy drugs include antihistamines, corticosteroids, decongestants, leukotriene receptor antagonists, mast cell stabilizers, and other related classes. Antihistamines function by blocking the action of histamine, a compound released by the immune system during allergic responses. These are used to manage various allergy types, including seasonal, perennial, food, skin, and insect bite allergies. Based on formulation, these medicines are available as tablets, capsules, syrups, nasal sprays, eye drops, and injectables. Distribution channels include online pharmacies, hospitals, retail pharmacies, clinics, and others, and they cater to diverse end-user groups such as children, adults, the elderly, and pregnant individuals.
The anti-allergy medicine market research report is one of a series of new reports from The Business Research Company that provides anti-allergy medicine market statistics, including the anti-allergy medicine industry global market size, regional shares, competitors with the anti-allergy medicine market share, detailed anti-allergy medicine market segments, market trends, and opportunities, and any further data you may need to thrive in the anti-allergy medicine industry. These anti-allergy medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The anti-allergy medicine market size has grown strongly in recent years. It will grow from $38.84 billion in 2024 to $42.25 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. This growth during the historic period can be credited to the increasing number of allergic conditions, heightened public awareness about allergy management, wider availability of over-the-counter allergy remedies, better access to healthcare services, and advancements in allergy diagnostic tools.
The anti-allergy medicine market size is expected to see strong growth in the next few years. It will grow to $58.47 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. Factors driving future growth include a rising global allergy burden, growing preference for rapid-relief medications, an aging population prone to allergies, the proliferation of e-pharmacy platforms, and enhanced governmental support for allergy education. Key trends expected in the market include innovations in drug delivery technologies, the emergence of non-drowsy antihistamines, advancements in customized allergy treatments, expanded R&D in biologic therapies, and the use of digital tools for managing allergic conditions.
The increasing prevalence of allergies is anticipated to drive the growth of the anti-allergy medicine market. Allergies are hypersensitive immune responses to allergens such as pollen, dust mites, certain foods, or pet dander, and can cause symptoms ranging from mild irritation to severe, potentially life-threatening reactions. These include hay fever, asthma, eczema, food allergies, and allergic rhinitis. The rise in allergy cases is largely attributed to growing environmental pollution, which can weaken the immune system and increase sensitivity to common allergens. Anti-allergy medicines provide targeted relief from these allergens, making them essential for managing conditions like hay fever, asthma, and eczema. These medications work by blocking histamines and other triggers, reducing immune overreactions and enhancing daily comfort and quality of life. For example, in November 2024, the Centers for Disease Control and Prevention reported that the number of people with asthma in the United States increased from 24,963,874 in 2021 to 26,799,588 in 2022. This rise in asthma cases underscores the expanding need for effective allergy treatments and supports the growth of the anti-allergy medicine market.
Key players in the anti-allergy medicine market are concentrating on the development of innovative therapies and obtaining regulatory approvals, such as monoclonal antibody treatments, to offer more targeted care, enhance treatment outcomes, reduce side effects, and address severe allergic conditions. Monoclonal antibody therapies are laboratory-engineered proteins designed to mimic the immune system's function by targeting and blocking specific immune pathways involved in allergic responses. This provides more precise and sustained symptom relief. For instance, in December 2024, Galderma SA, a pharmaceutical company based in Switzerland, received FDA approval for Nemluvio (nemolizumab-ilto) to treat adults and children aged 12 and older with moderate to severe atopic dermatitis. Used in combination with topical corticosteroids or calcineurin inhibitors, this monoclonal antibody acts as an interleukin-31 receptor antagonist, blocking IL-31 signaling-an important factor in inflammation and itching associated with atopic dermatitis-thereby helping improve skin condition and reduce symptoms.
In January 2024, Johnson & Johnson, a US-based pharmaceutical company, acquired Proteologix Inc. for $850 million. This acquisition was intended to bolster Johnson & Johnson's immunology portfolio by incorporating Proteologix's bispecific antibody programs, which are being developed to treat immune-mediated diseases such as atopic dermatitis and asthma. Proteologix Inc. is a biotechnology company in the United States that focuses on anti-allergy treatments using novel bispecific antibody therapies to target conditions like asthma and atopic dermatitis.
Major players in the anti-allergy medicine market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis AG, GSK plc, Amgen Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Perrigo Company plc, Cipla Limited, Dr. Reddy's Laboratories, Lupin Limited, Zydus Lifesciences Limited, Takeda Pharmaceutical Company Limited, Torrent Pharmaceuticals Ltd., ALK-Abello A/S, Torii Pharmaceutical Co. Ltd., Biomay Aktiengesellschaft, Kaleo Inc., Immunomic Therapeutics Inc., Circassia Group plc, Sun Pharmaceutical Industries Ltd., Anergis S.A., Aravax Pty Ltd., DBV Technologies S.A., and Desentum Oy.
North America was the largest region in the anti-allergy medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in anti-allergy medicine report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the anti-allergy medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The anti-allergy medicine market consists of sales of combination therapies, inhalers, nebulizers, auto-injectors, prefilled syringes, and transdermal patches. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Anti-Allergy Medicine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on anti-allergy medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for anti-allergy medicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The anti-allergy medicine market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Drug Class: Antihistamines; Corticosteroids; Decongestants; Leukotriene Inhibitors; Mast Cell Stabilizers; Other Drug Classes
2) By Type Of Allergy: Seasonal Allergies; Perennial Allergies; Food Allergies; Skin Allergies; Insect Sting Allergies
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Anti-Allergy Medicine Market Characteristics
3. Anti-Allergy Medicine Market Trends And Strategies
4. Anti-Allergy Medicine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Anti-Allergy Medicine Growth Analysis And Strategic Analysis Framework
5.1. Global Anti-Allergy Medicine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Anti-Allergy Medicine Market Growth Rate Analysis
5.4. Global Anti-Allergy Medicine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Anti-Allergy Medicine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Anti-Allergy Medicine Total Addressable Market (TAM)
6. Anti-Allergy Medicine Market Segmentation
6.1. Global Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antihistamines
Corticosteroids
Decongestants
Leukotriene Inhibitors
Mast Cell Stabilizers
Other Drug Classes
6.2. Global Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Seasonal Allergies
Perennial Allergies
Food Allergies
Skin Allergies
Insect Sting Allergies
6.3. Global Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tablets
Capsules
Syrups
Nasal Sprays
Eye Drops
Injectables
6.4. Global Anti-Allergy Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Online Pharmacy
Hospital
Offline Pharmacy
Clinic
Other Applications
6.5. Global Anti-Allergy Medicine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Children
Adults
Geriatric Population
Pregnant Women
6.6. Global Anti-Allergy Medicine Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
First-Generation Antihistamines
Second-Generation Antihistamines
Third-Generation Antihistamines
6.7. Global Anti-Allergy Medicine Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Corticosteroids
Nasal Corticosteroids
Inhaled Corticosteroids
Topical Corticosteroids
6.8. Global Anti-Allergy Medicine Market, Sub-Segmentation Of Decongestants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Decongestants
Nasal Spray Decongestants
Topical Decongestants
6.9. Global Anti-Allergy Medicine Market, Sub-Segmentation Of Leukotriene Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Leukotriene Receptor Antagonists
Leukotriene Synthesis Inhibitors
6.10. Global Anti-Allergy Medicine Market, Sub-Segmentation Of Mast Cell Stabilizers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cromolyn Sodium
Nedocromil Sodium
6.11. Global Anti-Allergy Medicine Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immunotherapy Agents
Biologics
Monoclonal Antibodies
7. Anti-Allergy Medicine Market Regional And Country Analysis
7.1. Global Anti-Allergy Medicine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Anti-Allergy Medicine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Anti-Allergy Medicine Market
8.1. Asia-Pacific Anti-Allergy Medicine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Anti-Allergy Medicine Market
9.1. China Anti-Allergy Medicine Market Overview
9.2. China Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Anti-Allergy Medicine Market
10.1. India Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Anti-Allergy Medicine Market
11.1. Japan Anti-Allergy Medicine Market Overview
11.2. Japan Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Anti-Allergy Medicine Market
12.1. Australia Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Anti-Allergy Medicine Market
13.1. Indonesia Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Anti-Allergy Medicine Market
14.1. South Korea Anti-Allergy Medicine Market Overview
14.2. South Korea Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Anti-Allergy Medicine Market
15.1. Western Europe Anti-Allergy Medicine Market Overview
15.2. Western Europe Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Anti-Allergy Medicine Market
16.1. UK Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Anti-Allergy Medicine Market
17.1. Germany Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Anti-Allergy Medicine Market
18.1. France Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Anti-Allergy Medicine Market
19.1. Italy Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Anti-Allergy Medicine Market
20.1. Spain Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Anti-Allergy Medicine Market
21.1. Eastern Europe Anti-Allergy Medicine Market Overview
21.2. Eastern Europe Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Anti-Allergy Medicine Market
22.1. Russia Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Anti-Allergy Medicine Market
23.1. North America Anti-Allergy Medicine Market Overview
23.2. North America Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Anti-Allergy Medicine Market
24.1. USA Anti-Allergy Medicine Market Overview
24.2. USA Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Anti-Allergy Medicine Market
25.1. Canada Anti-Allergy Medicine Market Overview
25.2. Canada Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Anti-Allergy Medicine Market
26.1. South America Anti-Allergy Medicine Market Overview
26.2. South America Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Anti-Allergy Medicine Market
27.1. Brazil Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Anti-Allergy Medicine Market
28.1. Middle East Anti-Allergy Medicine Market Overview
28.2. Middle East Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Anti-Allergy Medicine Market
29.1. Africa Anti-Allergy Medicine Market Overview
29.2. Africa Anti-Allergy Medicine Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Anti-Allergy Medicine Market, Segmentation By Type Of Allergy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Anti-Allergy Medicine Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Anti-Allergy Medicine Market Competitive Landscape And Company Profiles
30.1. Anti-Allergy Medicine Market Competitive Landscape
30.2. Anti-Allergy Medicine Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
31. Anti-Allergy Medicine Market Other Major And Innovative Companies
31.1. Sanofi S.A.
31.2. AstraZeneca plc
31.3. Novartis AG
31.4. GSK plc
31.5. Amgen Inc.
31.6. Teva Pharmaceutical Industries Ltd.
31.7. Regeneron Pharmaceuticals Inc.
31.8. Perrigo Company plc
31.9. Cipla Limited
31.10. Dr. Reddy's Laboratories
31.11. Lupin Limited
31.12. Zydus Lifesciences Limited
31.13. Takeda Pharmaceutical Company Limited
31.14. Torrent Pharmaceuticals Ltd.
31.15. ALK-Abello A/S
32. Global Anti-Allergy Medicine Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Anti-Allergy Medicine Market
34. Recent Developments In The Anti-Allergy Medicine Market
35. Anti-Allergy Medicine Market High Potential Countries, Segments and Strategies
35.1 Anti-Allergy Medicine Market In 2029 - Countries Offering Most New Opportunities
35.2 Anti-Allergy Medicine Market In 2029 - Segments Offering Most New Opportunities
35.3 Anti-Allergy Medicine Market In 2029 - Growth Strategies
